FDA Adverse Event Summary report: N

SCULPTRA

MDR report key: 2244008 · Received August 31, 2011

Report

Report Number
3002807108-2011-54569
Date Received
August 31, 2011
Date of Event
August 2, 2011
Report Date
August 31, 2011
Manufacturer
AVENTIS PHARMA GRUPPO LEPETIT S.R.L.
Product Code
LMH
PMA / PMN Number
P030050
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

PHARMACOVIGILANCE COMMENT: SANOFI-AVENTIS COMPANY COMMENT (B)(6) 2011: THERE IS A TEMPORAL RELATIONSHIP BETWEEN SCULPTRA INJECTION AND TRIGEMINAL NEURALGIA. AN INJECTION RELATED INJURY CANNOT BE RULED OUT. MRI RESULT WOULD PROVIDE A FURTHER INSIGHT INTO THE CAUSE. ADDITIONAL INFO ON THE OUTCOME OF THE EVENT AND MRI RESULT HAS BEEN REQUESTED.

Description of Event or Problem · 1

INITIAL INFO WAS RECEIVED FROM A PHYSICIAN (WHO IS ALSO PATIENT) ON (B)(6) 2011: AN ADULT FEMALE WITH NO SIGNIFICANT MEDICAL HISTORY RECEIVED HER FIRST AND ONLY SESSION WITH POLY-L-LACTIC ACID [SCULPTRA] LOT # AND EXPIRATION DATE NOT PROVIDED) FOR COSMETIC PURPOSES TO HER GLOBAL FACIAL AREA ON (B)(6) 2011. SHE STATED THE PROCEDURE WAS FLAWLESS AND IS EXTREMELY PLEASED WITH THE RESULTS. ON (B)(6) 2011 SHE HAD BEGUN TO EXPERIENCE SYMPTOMS OF TRIGEMINAL NEURALGIA IN HER FACIAL REGION. ON (B)(6) 2011, SHE SAW A NEUROLOGIST WHO CONFIRMED THE DIAGNOSES OF TRIGEMINAL NEURALGIA AND WAS IMMEDIATELY STARTED ON TREATMENT WITH ORAL DOSES OF OXCARBAZEPINE [TRILEPTAL]. TREATMENT WITH OXCARBAZEPINE CONTINUES AT THE TIME OF THIS REPORT AND SHE CONSIDERS THE EVENT OF TRIGEMINAL NEURALGIA AS RECOVERING. SHE IS UNSURE IF SHE CONSIDERS POLY-L-LACTIC ACID SUSPECT IN THE EVENT OF TRIGEMINAL NEURALGIA. THE NEUROLOGIST HAD SCHEDULED A MAGNETIC RESONANCE IMAGING SCAN [MRI] FOR (B)(6) 2011 TO RULE OUT ANY OTHER ANOMALY. NO FURTHER RELEVANT INFO PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SCULPTRA FACIAL FILLER LMH AVENTIS PHARMA GRUPPO LEPETIT S.R.L. UNK

Patients

Seq Age Sex Outcome Treatment
1 UNK Other CON MEDS =UNKNOWN| PREV MEDS =UNKNOWN